معرفی
Daniel Arve-Butler is an Associate Researcher in Infection Medicine at Lund University's Faculty of Medicine. His research focuses on innate immunity, therapeutic strategies for bacterial infections, and cancer biology. He leads the project "Cellular and bacterial basis of chronic Salmonella infection" (2024–2026), funded by the Swedish Society of Medicine.
Research interests include host-pathogen interactions, UTI treatments, and immunomodulation therapies. His work spans bacterial proteases' roles in cancer suppression and cytokine inhibition for acute infections. Notable contributions include studies on IL-1RA efficacy against antibiotic-resistant strains and peptide complexes for bladder cancer.
Publications emphasize translational research with high social media engagement (e.g., 321 shares for bladder cancer peptide therapy). Collaborations span international teams in microbiology, oncology, and urology. Projects demonstrate societal impact through news coverage and Mendeley readership (87+).
As Principal Investigator, he oversees grants totaling [unspecified amount], advancing chronic Salmonella infection studies. His lab integrates molecular mechanisms, clinical outcomes, and bacterial virulence factors.
